terutroban
Small moleculeexperimental
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Mechanism of action
- Thromboxane A2 receptorANTAGONIST
TBXA2R antagonist
Discontinueddue to lack of clinical benefit?
Chemistry & pharmacology
Loading structure…
SMILES
Cc1ccc2c(c1CCC(=O)O)CC[C@@H](NS(=O)(=O)c1ccc(Cl)cc1)C2- Mol. weight
- 407.92 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2107786 ↗
Also known as
- 3-((6-amino-(4-chlorobenzenesulfonyl)-2-methyl-5,6,7,8-tetrahydronapht)-1-yl)propionic acid
- 3-((6r)-6-(((4-chlorophenyl)sulfonyl)amino)-2-methyl-5,6,7,8 tetrahydro-1-naphthalenyl) propanoic acid, sodium salt
- s 18204
- s-18204
- s-18885
- s18886
- s-18886
- s-18886
- s-18886
- terutroban
- terutroban
- terutroban
- terutroban, sodium salt